Alfred Penhaskashi is a Encino, California based Periodontics who is specialized in Periodontology. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Alfred Penhaskashi is 41514 for Periodontology in California. His current practice location is 5363 Balboa Blvd, Ste # 226, Encino. Patients can reach him at 818-788-7091.
Alfred Penhaskashi is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Alfred Penhaskashi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1740368117
NPI Enumeration Date:
01 Nov, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Alfred Penhaskashi are as mentioned below.
License Number
Specialization
State
Status
41514
Periodontology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5363 Balboa Blvd, Ste # 226 Encino, California
Zip:
91316
Phone Number:
818-788-7091
Fax Number:
818-788-8876
Patients can reach Alfred Penhaskashi at 5363 Balboa Blvd, Ste # 226, Encino, California or can call to book an appointment on 818-788-7091. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.